Fig. 2: Clinical relevance of APOB ablation in hepatocellular carcinoma (HCC).
From: Clinical significance of APOB inactivation in hepatocellular carcinoma
a The Apob-silenced signature (ASS) was integrated with gene expression data from human HCC samples (The University of Texas MD Anderson Cancer Center cohort), and clustering was performed. Patients were stratified into two clusters according to their expressional similarity to mouse livers. b Kaplan–Meier plots of HCC patient overall survival (OS) in the MD Anderson Cancer Center cohort. Patients with the ASS had a poorer prognosis (lower OS rates) than those without the ASS
